Cargando…

Overcoming challenges to discover drugs for liver stages of Plasmodium vivax

Detalles Bibliográficos
Autor principal:	Kyle, Dennis E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179235/ http://dx.doi.org/10.1186/1475-2875-13-S1-O23

Ejemplares similares

Therapeutic disruption of Plasmodium vivax infected red cell deformability
por: Zhang, Rou, et al.
Publicado: (2014)

Plasmodium vivax Duffy binding protein: understanding targets of protective immunity
por: Adams, John H, et al.
Publicado: (2014)

The global distribution of Plasmodium vivax and G6PD deficiency prevalence
por: Hay, Simon I
Publicado: (2012)

Elimination challenges in the Pacific: vivax and submicroscopic parasitemia
por: McCarthy, James
Publicado: (2012)

Plasmodium vivax in Papua New Guinea: high diversity and gene flow among endemic populations signal roadblocks for elimination
por: Koepfli, Cristian, et al.
Publicado: (2012)

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

Chemotherapeutics for vivax malaria
por: Baird, J Kevin
Publicado: (2012)

Characterization of the Tubovesicular Network in Plasmodium vivax Liver Stage Hypnozoites and Schizonts
por: Sylvester, Kayla, et al.
Publicado: (2021)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
por: Alves, Eduardo, et al.
Publicado: (2014)

Integrating logic-based machine learning and virtual screening to discover new drugs
por: Reynolds, Christopher R, et al.
Publicado: (2012)

Genomic analyses of complex P. vivax infections
por: Chan, Ernest, et al.
Publicado: (2014)

Overcoming challenges of implementation of FBT at the Regional Eating Disorders Service (REDS) in Auckland, New Zealand
por: Mysliwiec, Roger, et al.
Publicado: (2014)

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
por: Roth, Alison, et al.
Publicado: (2018)

A comprehensive survey of protein palmitoylation in late blood-stage Plasmodium falciparum
por: Jones, Matthew L, et al.
Publicado: (2010)

Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3
por: Posfai, Dora, et al.
Publicado: (2020)

Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria
por: Chattopadhyay, Rana, et al.
Publicado: (2010)

Investigating transcriptional regulation of Plasmodium falciparum upon drug perturbation
por: van Brummlen, Tharina, et al.
Publicado: (2010)

Suppression of erythropoiesis by Plasmodium vivax infection
por: Panichakul, Tasanee, et al.
Publicado: (2010)

Characterization of the Plasmodium vivax erythrocytic stage proteome and identification of a potent immunogenic antigen of the asexual stages
por: Roobsoong, Wanlapa, et al.
Publicado: (2010)

Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
por: Roth, Alison, et al.
Publicado: (2018)

Dynamics of P. vivax clones in a cohort of children with or without primaquine treatment at baseline
por: Wampfler, Rahel, et al.
Publicado: (2014)

Liver-stage fate determination in Plasmodium vivax parasites: Characterization of schizont growth and hypnozoite fating from patient isolates
por: Vantaux, Amélie, et al.
Publicado: (2022)

The global challenge of antimalarial drug resistance
por: Ringwald, Pascal, et al.
Publicado: (2012)

Modeling the relapse distribution of Plasmodium vivax in different geographies
por: Eckhoff, Philip, et al.
Publicado: (2014)

Plasmodium vivax liver stage assay platforms using Indian clinical isolates
por: Subramani, Pradeep A., et al.
Publicado: (2020)

Transfection Models to Investigate Plasmodium vivax-Type Dormant Liver Stage Parasites
por: Voorberg-van der Wel, Annemarie, et al.
Publicado: (2023)

Plasmodium vivax Landscape in Brazil: Scenario and Challenges
por: Siqueira, Andre M., et al.
Publicado: (2016)

A3 TARGETING PROLINE METABOLISM TO OVERCOME TREATMENT RESISTANCE IN ESOPHAGEAL CANCER
por: Douchin, J, et al.
Publicado: (2022)

A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages
por: Schafer, Carola, et al.
Publicado: (2018)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
por: Kapulu, Melissa C, et al.
Publicado: (2010)

Overcoming CD4 deficiency to induce long-lived memory CD8(+ )CTL
por: Oh, SangKon, et al.
Publicado: (2006)

Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum
por: Wampfler, Rahel, et al.
Publicado: (2017)

Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
por: de Jong, Roos M., et al.
Publicado: (2019)

Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia
por: Rahmasari, Farindira Vesti, et al.
Publicado: (2022)

Adaptation of in vitro cytoadherence assay to Plasmodium knowlesi field isolates
por: Fatih, Farrah A, et al.
Publicado: (2010)

Stepwise dissection of Plasmodium falciparum merozoite invasion of the human erythrocyte
por: Riglar, David, et al.
Publicado: (2010)

Microsatellite characterization of Plasmodium vivax in pregnant women on the Thai–Myanmar border
por: Thanapongpichat, Supinya, et al.
Publicado: (2012)

Genetic variability of Plasmodium vivax from primary–relapses paired samples
por: Araujo, Flávia C, et al.
Publicado: (2012)

Novel phenotypic resistance to artemisinin results in reduced exposure to drug at the most sensitive stage of intraerythrocytic development in Plasmodium falciparum
por: Hott, Amanda, et al.
Publicado: (2014)

Overexpression of hepatocyte EphA2 enhances liver-stage infection by Plasmodium vivax
por: Chainarin, Sittinont, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqkadvr6t6lgp3etej5m3ntrif